The Antimicrobial Resistance Leadership Group (ARLG) (AAC ed.)

ARLG is changing the field of clinical research in antimicrobial resistance. We will talk with the Principal Investigators of the ARLG to discuss their strategy Objectives: • Review the history and accomplishments of ARLG • Discuss the missions of ARLG including training new clinical investigators focused on antibiotic resistance • Comment of the future of ARLG and clinical research on antibiotic resistance Joining me to talk about ARLG are the principal investigators of this ambitious effort: • Dr. Vance Fowler: Professor of Medicine, Florence McAlister Distinguished Professor of Medicine, Professor in Molecular Genetics and Microbiology, Duke University. • Dr. Henry "Chip" Chambers: Professor of Medicine, Emeritus. University of California, San Francisco Visit aac.asm.org to read the current issue.

There are no comments yet.

Please log in to write the first comment.